{"id":1425,"date":"2022-08-23T12:00:40","date_gmt":"2022-08-23T11:00:40","guid":{"rendered":"https:\/\/www.latestsale.com\/podcasts\/?post_type=episode&p=1425"},"modified":"2024-08-25T19:37:47","modified_gmt":"2024-08-25T18:37:47","slug":"health-equalities-programme-2022-investors","status":"publish","type":"episode","link":"https:\/\/www.latestsale.com\/podcasts\/episode\/health-equalities-programme-2022-investors\/","title":{"rendered":"HEALTH EQUALITIES PROGRAMME 2022: INVESTORS"},"content":{"rendered":"

SEASON 1:<\/p>\n

The third part of this sponsored podcast series as part of the Health Equalities Programme: COVID-19 THE INVESTORS, \u00a0A World Without Antibiotics: The Race towards Vaccinations has reached its summit. We explore; the role of investors in the MedTech sector during the roll out of vaccinations.<\/p>\n

 <\/p>\n

Skip to: 00:06<\/a> The role of investors in vaccination roll outs.<\/ins><\/p>\n

We explain the difference between biotechnology and genetic engineering. Most of us often use these terms interchangeably, but they differ. For starters, genetic engineering is a branch of biotechnology that modifies the genes of living organisms, while biotechnology uses living organisms to benefit humanity.<\/p>\n

 <\/p>\n

Skip to: 03:15<\/a> Biotech market size and the investors that count.<\/ins><\/p>\n

The biotech market holds a net worth of $793.87 billion. The most prominent investors in this field include RA Capital Management and OrbiMed, which invested $6.1 billion and $6 billion in the R&D of pharmaceuticals relating to Covid-19, which, of course, included vaccines, with the aim of influencing vaccine uptake to reach the target of getting at least 70% of the population in each country vaccinated.<\/p>\n

 <\/p>\n